Cfo Thought Leader

A brief summary of this episode

CFOTL: What are the numbers or metrics that are always top of mind for you?  Shelly: Ninety-five percent of our revenue is driven by the volume that we clear, settle, and risk-manage every day, which is something that we don't control. We charge a clearing fee for our services, and as a low-cost service provider, I can't just charge any old amount. I'm very cognizant of how much volume we clear every day because our budget is based on an average daily volume rate. I'm also very cognizant of expenses. I'm okay with spending money, but I want to do it in a smart way. Last year, we began what we call our Renaissance initiative. It's a multiyear, multimillion-dollar program through which we are replacing our core technologies. The system that clears, settles, and risk-manages those positions every single day is about 20 years old, so we are looking to create a more modular, more agile system whereby we can increase our processing, we can better utilize the data that we receive every single day, and we can expand

Few megadeals within the past decade have received as many recurring kudos as the acquisition of Genzyme, of Cambridge, MA by France’s biggest pharmaceutical company, Sanofi. The marriage of Sanofi and Genzyme appears to have exceeded expectations, allowing all of those involved in minting the newly merged entity to rightfully keep a feather in their postmerger caps. Thus it was for Mike Kaseta, who in the wake of the merger found himself tasked with integrating the finance and IT functions of the two companies. “It’s probably the achievement that I’m most proud of in my career,” explains Kaseta, who, after nearly a decade climbing the finance ranks inside Sanofi, exited the giant pharmaceutical company to stake a claim inside the realm of early-stage biotech, where today he is CFO of Aerami Therapeutics. Looking back, Kaseta believes that the greatest lessons he gleaned from the Sanofi–Genzyme merger were people-related: “There was no iron fist. We listened to employees. We understood. In the end, we had no

Among the many lessons that David Moss has learned along the trajectory of his 25-year finance career, the one to which he refers simply as “the $3 million sweatshirt” is perhaps the most enduring. Even after 20 years, Moss can’t help but mention the sweatshirt bearing the logo of Pets.com, which he kept as a souvenir from an earlier career chapter involving a $3 million investment in the infamous dot-com retailing upstart. Pets.com began operations in November 1998 and shut down in November 2000, becoming one of the more high-profile victims of the dot-com bubble. However, looking back, Moss says that while the economy’s sudden gyrations certainly contributed to the firm’s demise, other mistakes also came into play, including the filling of leadership roles with executives from large enterprise companies. “Someone from a large business often has a difficult time in adjusting to dynamic environments where you have to get your hands dirty and wear all of the hats and take the trash out,” says Moss, who clearly

Ravi Chopra has built his career inside finance functions designed to serve growth-minded management. Such was the case in the late ’90s when Chopra joined Cisco Systems, which at the time was experiencing 50% growth annually. Jump forward 10 years, and you’ll find him busy leading the FP&A function for growth-driven Juniper Networks. Asked to reflect back on a 25-year finance career, Chopra doesn’t hesitate to cite his former employer. “I learned most of everything that I know today at Juniper,” says Chopra, who quickly names Robyn Denholm, Juniper’s former CFO and current Tesla chairman, as a present and former mentor. Still, when the door to the CFO office swung open for Chopra, the accomplished finance executive no doubt found his operations knowledge being put to the test. In 2017, Chopra would exit Juniper Networks and take on the CFO role at SonicWall, a company that had neither a finance nor an HR organization after it split off from Dell, Inc., in late 2016. Dell had acquired SonicWall in 2012 bu

Had Valerie Burman entered the CFO office a decade ago, you wonder whether the role would be as good a match for the accomplished finance executive as it appears to be today. Back in 2007, after working nearly a decade in M&A as an investment banker, Burman exited a banking career to take on a corporate development role at Business Objects, a French software company that was soon to be acquired by SAP. Post acquisition, Burman quickly found a groundswell of opportunities coming her way inside SAP, where she would serve in a variety of roles involving technology partnerships, business development, and product management.  Fast-forward a few years, and we find Stanford Law graduate Burman serving as general counsel first to Mindjet and then to crowdsourcing innovation upstart Spigit. “I would say that working from those perspectives—although it is a bit of a roundabout way to become a CFO—has really led me to a place where I can be a CFO with a business-minded, strategic approach,” says Burman, who points o

When Chris Sands accepted an investor relations position at a midsize health care firm, he did so with the understanding that he would be permitted to occasionally sink his teeth into some of the firm’s growing FP&A challenges. Having a resume rich with investment banking experience, Sands was now determined to add some FP&A, a tour of duty that he viewed as a necessary prerequisite if he were going to advance down the CFO path. Unbeknownst to Sands, his FP&A plate would shortly be overflowing following the acquisition of his new employer by Thermo Fisher Scientific of Waltham, Massachusetts. In the aftermath, Sands was enlisted to help lead the science giant’s planning function, which allowed him to dine regularly on high-calorie planning and begin to consider his next opportunity. Sands would open what he views as the third chapter of his career at MineralTree, after having been recruited by CEO Micah Remley, with whom Sands had worked earlier in his career. “Anytime a company is looking to hire

For every top sales leader who confides to friends that he or she is really a numbers freak at heart, there’s an Andrew Hicks, who, as CFO of Advanced, would be just as apt to boast about a sales funnel innovation as he would about the adoption of a new accounting rule. In fact, it would probably not surprise Hicks’s past and present business colleagues to learn that when asked to identify a mentor from his past, Advanced’s CFO chooses the head of sales for a former employer. “It was because of this relationship that I first experienced an inkling of how people can think about the business differently and think differently about what drives value in the firm,” explains Hicks, who found his mentor after being transferred to Austin from London by Misys, a UK-based software developer that today is part of Finastra. “I had moved across the world, and the sales leader took me under his wing a bit as someone new in the U.S. who didn’t really have family or friends nearby. Talking to him really piqued my interest in

As is the case with many finance leader resumes, Cort Townsend’s reveals a repetition of professional advancement and achievement that allows casual readers to quickly validate his CFO credentials. However, like those of many, Townsend self-tale is only a shorthand rendering of a career path filled with twists, turns, and high-stakes industry drama. Such was the case in 2015 and 2016, a period in Townsend’s career annals with enough M&A high jinks and boardroom intrigue to fill an entire volume. Subsequently, though, in July 2017, Townsend landed neatly inside the CFO office of Kofax via an appointment that casual readers of his resume might have assumed was the natural next step for a dedicated senior executive who had already served as the firm’s controller and vice president of finance. So, where was all the drama? Lost between the lines of Townsend’s resume was the acquisition of Kofax by Lexmark International in 2015 and the subsequent acquisition of Lexmark by Apex Technology in 2016. Along the way,

A brief summary of this episode

CFOTL: What are your top of mind metrics? Karnes: I think about metrics sort of under three rubrics. The first is what I would think of as a customer-centric layer. Then there's the financial performance one that we all think about as CFOs, and then there's a very distinct operational layer. On the customer-centric layer, we think about things like SLAs, our service-level agreements with our customers, uptime, system availability. These are the things--before we get to gross margin--that really impact our success as a business and what our next quarter is going to be like. There are things like customer health scoring in your customer success organization. Happy customers don't leave. Keeping your revenue is much cheaper than trying to go acquire new revenue. Things like NPS, net promoter score. Things that I watch very, very carefully are very customer-centric, as opposed to what's next, which is more pure financial performance. At the end of the day, your economics are based on your base business, your ne

When asked what sets BioXcel Therapeutics apart from other clinical-stage biopharmaceutical companies, CFO Richard Steinhart doesn’t mention a specific drug or therapy. Instead, he describes a system that the company developed to advance the speed with which drugs are commercialized. According to Steinhart, the biotech company’s system uses artificial intelligence to reveal “hidden connections” that, once exposed, can multiply opportunities for the application of certain drugs. “Good drug developers can see first connections between drugs and diseases and they are pretty apparent to everyone out there, but second- and third-degree connections are not apparent,” explains Steinhart, who says that such connections have been too time-consuming and expensive to expose in the past. “The last company I was with took 10 years to go from the discovery (of a drug to the licensing of the discovery to a phase two trial,” adds Steinhart, who reveals that it was BioXcel’s system for shortening the path to commercialization

The way Ken Stillwell tells it, his career as a CFO can be divided into two distinct worlds: the world before ARR and the world after ARR. ARR, of course, is the acronymic identifier for the widely used SaaS metric known as annual recurring revenue. Stillwell prefers to put his own twist on the acronym by declaring its actual meaning to be annual recurring relationships—as in client relationships. Says Stillwell: “Whatever metric you use to measure recurring relationships is really misunderstood in the marketplace until you start to track it.” What happens next has led many a finance leader to shout, “Where have you been all my life!” Or so Stillwell might have us believe in light of his evident passion for the metric and the singular emphasis that he places on it when asked about the career chapter that he has opened as CFO of Pegasystems, a firm specializing in customer engagement solutions. “Once CFOs track it and begin reporting it, its value becomes so obvious—not just the value of the metric, but also t

Few finance leaders have boiled down the take-aways from their career journeys into as many palatable, bite-size portions as John Pokorney, CFO of LeTip International. Having found his original finance door of entry at Intel Corp. in the early 1990s, Pokorney credits the chipmaker’s collaborative culture for prodding him to speak the language of others and tap the power of narrative. “I wasn’t there to create numbers for the engineering group that I was working with or the logistics organization that I ended up supporting, but I was there to be a business partner—and when you’re a business partner, you have to talk the language of the group you’re working with,” explains Pokorney, who would enter the ranks of entrepreneur CFOs after leaving Intel, where in a span of eight years he occupied the roles of finance analyst, finance manager, and group controller. Reflecting on a number of different CFO tours of duty, Pokorney is able to quickly bring forth detailed memories of different places and times when busine

After years of careful finance career–building within the healthcare sector, Paul Willson came upon an opportunity inside Austin’s energetic technology start-up community that he found hard to resist. Becoming employee number 23, he was immediately dubbed “the finance guy”—a label that he would wear for only 5 days before the ambitious start-up announced that it was being acquired by BMC Software. At the time, Willson no doubt harbored some frustration concerning the timing of his arrival in the realm of entrepreneurial tech. However, in the weeks and months to come, the conventional wisdom that had fueled the tech community’s bravado would be stood on its head as the dot-com crash of 2000 scorched the entrepreneurial landscape and ended the life of many a start-up. Back at BMC, Willson weathered the storm and joined their finance rank-and-file, where he grew accustomed to the ebb and flow of the technology world before jumping to Convio, a small, Austin-based, technology firm with IPO ambitions. “It was a gr

­­­When it comes to guessing a person’s email address, most of us would agree that the best way to optimize your odds of success is to first assume that the person was using their actual name as part of the address. From there, your next decision arguably is whether to spell out the individual’s first name or use an initial for it. For Tim Zue, the calculation behind one guess was a bit more nuanced because although the first name of the person he was emailing was Lawrence, the man was widely known as Larry. With little to lose, Zue addressed the email to LLucchino@redsox.com. Sixteen years later, Zue is CFO of the Boston Red Sox, and his “initial decision” sticks with him perhaps as a reminder that every carefully built career contains serendipitous moments. Still, the email that Boston Red Sox then-CEO Larry Lucchino received from Zue did not come from a career-minded controller or accountant, and it was not a job inquiry. At the time, Zue was teaching 8th-grade math in the Boston public school system, and

As an Indian citizen living in the United States and working for a Dutch company, CFO Smital Shah frequently spends her days on conference calls with investors from Asia, Israel, or Europe. On every investor call, at every board meeting, and at every employee gathering, the same question gets asked: “How far is ProQR from serving patients?” Each time she hears this, the firm’s worldly finance leader provides a thoughtful and measured response. This is a question that punctuates the tenure of finance chiefs inside every clinical stage start-up, and one that Shah says has led her to seek out any synergies that she can between the finance function’s accounting and compliance processes and ProQR’s greater goal of creating medicines for patients who suffer from rare diseases. Shah asks: “How do we facilitate—within the confines of finance—what we need to do in order to achieve this?” ProQR expects to have collected the necessary data from its ongoing clinical trials to seek out approval for its new medicine from t

Like a savvy investor, Lucy Rutishauser built her early career by carefully tracking the activities of different companies. Sometimes, to glean better insights, she would actually cold-call a company and ask for the finance department. But Rutishauser wasn’t looking to invest money—instead, she was looking to invest that all-so-valuable commodity known as career-building years. “The take-away here is that as you are growing your professional career and moving from job to job, it’s crucial that the decisions that you make be valuable to a future employer and not just great for your bank account at that moment,” says Rutishauser, who would join Sinclair Broadcast Group after placing just such a cold call back in 1998. Providing some additional background on what led her to originally place the call, Rutishauser explains: “I had been reading about Sinclair rolling up the industry and driving industry consolidation. They were located here in Baltimore, which is where I live. I figured that they were probably goin

While tours of duty at struggling companies are seldom viewed as enviable career chapters for most professionals, finance leaders are often apt to savor the lessons that such tours of duty bring forth and even draw attention to such early chapters. Such is the case with CFO Jason Lin, whose career journey includes chapters with a rapidly rising juggernaut (TripAdvisor) as well as with the revitalization of a flickering fallen star (Monster.com). When asked why he singles out his “Monster chapter” as an experience that prepared him for a finance leadership role, Lin recalls the valuable lessons learned from “having to manage people through tough times—to motivate them without being able to offer a bonus or a salary increase and still be able to move the team forward.” “There are challenges in both environments, and I think that having been at both ends of the spectrum has been beneficial for me,” says Lin, while quickly segueing to his days at TripAdvisor, where a cash-rich balance sheet and seemingly unlimite

The mass migration of software developers from perpetual licensing to subscription licensing models has allowed quite a few CFOs to enrich their strategy credentials in recent years. It’s a movement that has allowed finance chiefs to rebrand themselves as champions of change, and one that has helped to dismiss the image of CFOs being the C-suite’s most dependable naysayers. Nevertheless, saying “no” to a migratory deadline is what CFO William Edmondson counts as one of his career’s most memorable finance strategic moments. As CFO of 1E—a UK-based IT software and services company—and like other top officers, Edmondson nurtured a sense of urgency for the adoption of the new licensing model but at the same time remained wary of mandatory deadlines.  “Just as I had finally gotten reasonably comfortable with the fact that we were ready to do it—just as we were going to go ‘live’—there was a bit of a downturn in the business and I actually said ‘No, we have to pull it.’ Even though it was the right strategic thing